Diagnosis

Sentinel Lymph Node Biopsy for Early-Stage Breast Cancer

To help doctors give their patients the best possible care, the American Society of Clinical Oncology (ASCO) asks its medical experts to develop evidence-based recommendations about specific topics in cancer care. This recommendation is about the use of sentinel lymph node biopsy for patients with early-stage breast cancer. This guide for patients is based on ASCO's recommendations.

Key Messages:

HER2 Testing for Breast Cancer

To help doctors give their patients the best possible care, the American Society of Clinical Oncology (ASCO) asks its medical experts to develop recommendations for specific areas of cancer care. In 2013, ASCO and the College of American Pathologists (CAP) issued an updated joint clinical practice guideline about human epidermal growth receptor 2 (HER2) testing for breast cancer. This guide for patients is based on ASCO and CAP’s recommendations.

Key Messages:

Prostate-Specific Antigen (PSA) Testing for Prostate Cancer Screening

Introduction

The American Society of Clinical Oncology (ASCO) has issued a provisional clinical opinion on the use of PSA testing to screen for prostate cancer in men with no symptoms of the disease. A provisional clinical opinion offers direction to doctors and others after the publication or presentation of information that could change screening, testing, or treatment decisions.

About Prostate Cancer and PSA Testing

Lung Cancer Screening

To help doctors give their patients the best possible care, the American College of Chest Physicians (ACCP) and the American Society of Clinical Oncology (ASCO) developed evidence-based recommendations on using computed tomography (CT) scans to screen for lung cancer in people who smoke or who have previously quit smoking. This guide for patients is based on the ACCP and ASCO recommendations.

Key Messages

Tumor Markers for Testicular Cancer and Extragonadal Germ Cell Tumors in Teenage Boys and Men

To help doctors give their patients the best possible care, the American Society of Clinical Oncology (ASCO) asks its medical experts to develop evidence-based recommendations for testing blood levels of tumor markers for germ cell tumors. The tumor markers recommended in this guide are based on the results of clinical trials of patients with germ cell tumors. 

Watch a patient education video led by Dr. Timothy Gilligan explaining this ASCO guideline on tumor markers for this specific type of tumor.

Estrogen and Progesterone Receptor Testing for Breast Cancer

To help doctors give their patients the best possible care, the American Society of Clinical Oncology (ASCO) and the College of American Pathologists (CAP) developed evidence-based recommendations to improve the accuracy of testing for estrogen and progesterone receptors for breast cancer. This guide for patients is based on ASCO's and CAP's recommendations.

Key Points:

Tumor Markers for Breast Cancer

To help doctors give their patients the best possible care, the American Society of Clinical Oncology (ASCO) asks its medical experts to develop recommendations for specific areas of cancer care. ASCO developed a clinical practice guideline about tumor markers for breast cancer. This guide for patients is based on ASCO's recommendations.

Key Messages:

Pages

Subscribe to RSS - Diagnosis